P
ProteinQure
Computational protein design
About ProteinQure
ProteinQure is a biotechnology company specializing in the computational design of peptides for precise tissue-specific therapeutic delivery. Operating in the precision medicine market, ProteinQure serves pharmaceutical companies and research institutions looking to enhance the efficacy of their treatments while minimizing side effects. The company's proprietary peptides are designed to deliver therapeutic payloads directly to disease-inducing cells via receptor-mediated endocytosis, ensuring targeted treatment. ProteinQure's business model revolves around partnerships and collaborations with pharmaceutical firms, generating revenue through licensing agreements and milestone payments. By leveraging a cross-disciplinary team of experts in Experimental Biology, Software Engineering, Machine Learning, and Computational Biology, ProteinQure aims to transform drug development and offer new hope to patients with previously untreatable diseases.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Toronto, Canada
- Employees
- 32
- Open positions
- None listed
- Dealroom signal
- 67.9/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Quantum Computing, Core AI, Precision Medicine
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning, Quantum Technologies
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | May 2026 | $1.3M | — | FedDev Ontario | ↗ |
| GRANT✓Other financing | Apr 2026 | $1.9M | — | Genome Canada · Ontario Genomics | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for ProteinQure is 7.9K monthly website visits, up 41.1% over the last three months. ProteinQure's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed9 investors entered at this stage
Creative Destruction Lab
Felicis
8VC
Global Founders Capital
Tom Williams
Inovia Capital
Genome Canada
Ontario Genomics
FedDev Ontario
Series A3 investors entered at this stage
Golden Ventures- HFHeron Rock Fund
Kensington Capital Partners
Series B and later1 investor entered at this stage
Government of Canada
Other known investors5 additional known investors
Google for Startups Accelerator
University of Toronto
Bloomberg Beta
Endless Frontier Labs
Ramen Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ProteinQure on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ProteinQure’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.